Chris Kern currently serves as an Analyst with Keswick. Chris is responsible for deal execution, due diligence, financial analysis, and portfolio management. He also supports deal origination and marketing.
Prior to joining Keswick, Chris was an Associate at TGH Innoventures, Tampa General Hospital’s venture capital group, where he supported the investment team in sourcing new investment opportunities, deal underwriting, and portfolio monitoring.
Chris received a B.S. degree in Finance from Florida State University.